These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2014035)

  • 1. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest.
    Brain Resuscitation Clinical Trial II Study Group
    N Engl J Med; 1991 May; 324(18):1225-31. PubMed ID: 2014035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of calcium entry blocker administration to comatose survivors of cardiac arrest. Design, methods, and patient characteristics. The Brain Resuscitation Clinical Trial II Study Group.
    Control Clin Trials; 1991 Aug; 12(4):525-45. PubMed ID: 1657528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability of the brain and heart after cardiac arrest.
    Plum F
    N Engl J Med; 1991 May; 324(18):1278-80. PubMed ID: 2014039
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest.
    Brain Resuscitation Clinical Trial I Study Group
    N Engl J Med; 1986 Feb; 314(7):397-403. PubMed ID: 2868412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs.
    Vaagenes P; Cantadore R; Safar P; Moossy J; Rao G; Diven W; Alexander H; Stezoski W
    Crit Care Med; 1984 Oct; 12(10):846-55. PubMed ID: 6488823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lidoflazine in the treatment of comatose survivors of cardiac arrest.
    Engler RL
    N Engl J Med; 1991 Oct; 325(14):1046-7. PubMed ID: 1886630
    [No Abstract]   [Full Text] [Related]  

  • 7. Early amelioration of neurologic deficit by lidoflazine after fifteen minutes of cardiopulmonary arrest in dogs.
    Winegar CP; Henderson O; White BC; Jackson RE; O'Hara T; Krause GS; Vigor DN; Kontry R; Wilson W; Shelby-Lane C
    Ann Emerg Med; 1983 Aug; 12(8):471-7. PubMed ID: 6881642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asphyxiation versus ventricular fibrillation cardiac arrest in dogs. Differences in cerebral resuscitation effects--a preliminary study.
    Vaagenes P; Safar P; Moossy J; Rao G; Diven W; Ravi C; Arfors K
    Resuscitation; 1997 Aug; 35(1):41-52. PubMed ID: 9259060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Old age does not negate good cerebral outcome after cardiopulmonary resuscitation: analyses from the brain resuscitation clinical trials. The Brain Resuscitation Clinical Trial I and II Study Groups.
    Rogove HJ; Safar P; Sutton-Tyrrell K; Abramson NS
    Crit Care Med; 1995 Jan; 23(1):18-25. PubMed ID: 8001370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological recovery after cardiac arrest: clinical feasibility trial of calcium blockers.
    Schwartz AC
    Am J Emerg Med; 1985 Jan; 3(1):1-10. PubMed ID: 3882095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium blockers in cerebral resuscitation.
    White BC; Winegar CD; Wilson RF; Krause GS
    J Trauma; 1983 Sep; 23(9):788-94. PubMed ID: 6620432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of the ischemic canine myocardium: a comparison of hypothermia, lidoflazine, and ketanserin.
    Clark NJ; Port JD; McJames SW; Stockham RJ; Stanley TH; Pace NL
    J Cardiothorac Anesth; 1988 Jun; 2(3):330-40. PubMed ID: 17171869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk monitoring of randomized trials in emergency medicine: experience of the Brain Resuscitation Clinical Trial II.
    Sutton-Tyrrell K; Snyder JV; Kelsey S; Abramson N
    Am J Emerg Med; 1991 Mar; 9(2):112-7. PubMed ID: 1994935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurologic outcomes after cardiac resuscitation.
    Shively M; Norton L; Mendez K
    J Cardiovasc Nurs; 1996 Jul; 10(4):93-6. PubMed ID: 8796493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of carbon dioxide, lidoflazine and deferoxamine upon long term survival following cardiorespiratory arrest in rats.
    Badylak SF; Babbs CF
    Resuscitation; 1986 Apr; 13(3):165-73. PubMed ID: 3012732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium blockers after cardiac arrest: history repeats itself.
    Abramson N
    Am J Emerg Med; 1985 Jan; 3(1):82-3. PubMed ID: 3882097
    [No Abstract]   [Full Text] [Related]  

  • 17. Pretreatment with lidoflazine, a calcium-channel blocker. Useful adjunct to heterogeneous cold potassium cardioplegia.
    Kates RA; Dorsey LM; Kaplan JA; Hatcher CR; Guyton RA
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):278-86. PubMed ID: 6823146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidoflazine does not improve neurologic outcome when administered after complete cerebral ischemia in primates.
    Fleischer JE; Lanier WL; Milde JH; Michenfelder JD
    J Cereb Blood Flow Metab; 1987 Jun; 7(3):366-71. PubMed ID: 3584269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of initial intervention on long-term neurological recovey after cardiac arrest: data from the Luxembourg "North Pole" cohort.
    Stammet P; Collas D; Werer C; Muenster L; Clarens C; Wagner D
    Bull Soc Sci Med Grand Duche Luxemb; 2012; (1):60-70. PubMed ID: 22822564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative morphological assessment of the effect of lidoflazine and deferoxamine therapy on global brain ischaemia.
    Kumar K; White BC; Krause GS; Indrieri RJ; Evans AT; Hoehner TJ; Garritano AM; Koestner A
    Neurol Res; 1988 Sep; 10(3):136-40. PubMed ID: 2905775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.